MSOS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

MS

Volume

5.99M

Loading chart

MS

MSOSAdvisorShares Pure US Cannabis ETF

MSOS

Pay with—

Available Balance0.00

MS

AUM

N/A

Volume

5.99M

Yield

1.80%

Chart Earnings News About Insider Filings

Trulieve Makes History As First US Cannabis Stock On NYSETrulieve Cannabis Corp. became the first U.S. cannabis company to list on a major U.S. stock exchange (NYSE: TRLV), enabled by the Trump administration's reclassification of cannabis to Schedule III. The company separated its medical and adult-use operations to meet exchange requirements. Competitors like Curaleaf and Verano are preparing for similar uplistings, while Canadian producers remain on Nasdaq. The listing has energized the cannabis sector.Benzinga · Jun 10, 2026

Trump Just Eased Federal Marijuana Laws. Is there an Investment Case for Cannabis ETFs Right Now?The Justice Department reclassified state-licensed marijuana from Schedule I to Schedule III, with a June hearing planned for recreational marijuana reclassification. This follows President Trump's executive order to downgrade cannabis to a less restrictive category. The move could ease the cannabis industry's banking access and tax burden issues, potentially increasing demand and state legalization efforts.The Motley Fool · Apr 24, 2026

Wall Street Is Betting on More Than MarijuanaAn executive order fast-tracking psychedelic medicines to market has bifurcated the alternative drug sector. Psychedelic stocks like Compass Pathways and Atai Beckley surged 40% and 20% respectively due to regulatory tailwinds and short squeezes, while mature cannabis operators like Curaleaf and Innovative Industrial Properties are now valued as stable, cash-generating businesses rather than speculative plays.Investing.com · Apr 21, 2026

Trump's Cannabis Rescheduling Order Could Finally Kill A Crushing Tax Rule And Transform US Weed Stocks, Says ExpertPresident Trump's executive order to reschedule cannabis to Schedule 3 could eliminate Section 280E of the Internal Revenue Code, allowing U.S. cannabis operators to deduct business expenses for the first time. This represents the most significant federal cannabis policy shift in over 50 years. However, challenges remain including inability to list on major exchanges and lack of banking safe harbor provisions.Benzinga · Jan 19, 2026

Trump's Marijuana Order Is Lighting Up This Cannabis ETF: Momentum Score SpikesThe AdvisorShares Pure U.S. Cannabis ETF (MSOS) is experiencing a significant momentum surge following the Trump administration's reclassification of marijuana. The ETF's Momentum score jumped from 24.75 to 88.95 in just over a week, driven by renewed industry optimism and strong earnings from Tilray Brands. The reclassification is expected to boost profitability by allowing companies to deduct standard business expenses.Benzinga · Jan 9, 2026

High Hopes: Pot Stocks Blaze As Trump Eyes ReschedulingPresident Trump is considering rescheduling marijuana from Schedule I to Schedule III, which could potentially remove tax burdens on cannabis businesses and improve their financial prospects.Benzinga · Dec 17, 2025

Trump Weighs Marijuana Changes: 'A Lot Of People Want To See It'President Trump is considering an executive order to reclassify marijuana as a Schedule III substance, which could transform the cannabis market, reduce legal punishments, and facilitate scientific research.Benzinga · Dec 15, 2025

1 Major Reason Cannabis Stocks Surged This WeekMarijuana stocks experienced significant gains after Donald Trump's video promoting hemp-derived CBD benefits and potential marijuana reclassification, with several cannabis companies and ETFs seeing notable price increases.The Motley Fool · Oct 1, 2025

President Trump Lights Up Cannabis Stocks With Pro-CBD Truth Social PostPresident Trump posted a video on Truth Social promoting CBD's potential health benefits, suggesting Medicare coverage and potential healthcare system integration. This sparked a significant rally in cannabis stocks, with multiple companies seeing substantial price increases.Benzinga · Sep 29, 2025

Is Tilray Brands a Dirt Cheap Growth Stock or Just a Bad Buy?Tilray Brands, a cannabis and beverage company, has diversified its operations but continues to struggle with profitability. Despite recent stock rallies, the company has lost 90% of its value since 2022 and remains a high-risk investment with uncertain growth prospects.The Motley Fool · Jul 31, 2025

to start trading

MS

MSOSAdvisorShares Pure US Cannabis ETF

MSOS

Pay with—

Available Balance0.00

Your PositionYou don't own any MSOS yet.

Related Tickers

Earnings